1st Quarter - Report
FABIANI & COMPANY for VAXINNATE
Firm
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 17, 2009 | $60,000 | Yes |
| 1st Quarter - Termination | Jul 17, 2009 | — | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY | — |
| JAMES P FABIANI | — |
| WENDY SHELTON | — |
Budget/Appropriations BUD
Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY | — |
| JAMES P FABIANI | — |
| WENDY SHELTON | — |
Pharmacy PHA
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY | — |
| JAMES P FABIANI | — |
| WENDY SHELTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.